|
|
Post by JEvans on Jun 27, 2020 20:38:20 GMT -5
As a private Investor, my job is to invest my money and make money! Not to invest my money and lose my money! I work hard for my money and when I invest I expect to see a return.
As a public company, Mannkind Corporation's job is to make their investors money. In this case, their job is to make me money. I invested in them, I will hold them accountable, and I will expect to see a return.
So far, I'm underwater and holding my breath. I failed as an investor and Mannkind management has failed me. Like I said I haven't quit, I'm holding my breath, but Mike, I'll need oxygen soon, please don't quit me!
|
|
|
|
Post by peppy on Jun 28, 2020 17:37:26 GMT -5
As a private Investor, my job is to invest my money and make money! Not to invest my money and lose my money! I work hard for my money and when I invest I expect to see a return. As a public company, Mannkind Corporation's job is to make their investors money. In this case, their job is to make me money. I invested in them, I will hold them accountable, and I will expect to see a return. So far, I'm underwater and holding my breath. I failed as an investor and Mannkind management has failed me. Like I said I haven't quit, I'm holding my breath, but Mike, I'll need oxygen soon, please don't quit me! I can't breathe......... ok, I'll stop ditto Jevans |
|
|
|
Post by joeypotsandpans on Jun 28, 2020 17:48:46 GMT -5
As a private Investor, my job is to invest my money and make money! Not to invest my money and lose my money! I work hard for my money and when I invest I expect to see a return. As a public company, Mannkind Corporation's job is to make their investors money. In this case, their job is to make me money. I invested in them, I will hold them accountable, and I will expect to see a return. So far, I'm underwater and holding my breath. I failed as an investor and Mannkind management has failed me. Like I said I haven't quit, I'm holding my breath, but Mike, I'll need oxygen soon, please don't quit me! They haven't failed me as a customer and for this reason alone a portion of my money continues to be invested in them, having said that, it doesn't mean you are precluded from other investments. It's the choices we make where accountability lies, I take full responsibility for my own actions and decisions after doing my own due diligence. You can read and choose to listen to others opinions etc., but at the end of the day it's the choices we make whether to remain invested. This has and remains a speculative investment, key word is speculative...high risk, high reward. If I wanted a conservative investment with expected returns I would be in a large cap with a stable history of dividends. The history of this investment is very indicative of what comes with a speculative investment. Thus why I have said in the past, it's a Rip Van Winkle stock, hopefully one day I wake up to a nice surprise but I don't watch it like a pot about to boil. Even MTOI says one day hopefully his daughter will wake up with a lot of money  |
|
|
|
Post by mytakeonit on Jun 28, 2020 18:10:57 GMT -5
Sorry joey ... but it happened already. It appears she has the same "curse" that I have. We both do everything we can to remedy the situation, but we wake up with more $$$ than the night before. It was a nightmare going to Las Vegas where THE LOSING GAME is supposed to be the slot machines ... but I come home with more $$$ than when I left. AND, I almost hit Megabucks to boot !!! I would have had to commit Hara-Kiri !!!
MNKD will see shares price go to $10 ... then $100 ... then $200 ... and on and on and on. It's a curse I tell you !!!
But, that's mytakeonit
|
|
|
|
Post by itellthefuture777 on Jun 29, 2020 11:07:40 GMT -5
As an invested my role is to put money where I think it can work to help people live fuller better lives. If I am right in my selection then I have done a good thing. First one must have cash cash cash for those filling an unmet needs..great people, Leadership..etc..
Now if I wanted a 3% CD...with little risk..that like this would be my choice.
But the feeling one gets knowing it's worth that risk when you see a youtube video of Jake..a kid..able to be living longer..better..with less risk..then that Makes it worth every damned penny...to me. As with every investment comes the risk of failure...but Afrezza patients thrive..are happy..that's not failure coming forth...sure there was that dirty short business to roll over..but now..there are 30 million shorts and possible very large partnerships with no reason now for them not to cover...and that will be their choice...to cover now ..before cannibalizing themselves..or after..where we see claw marks going into an inferno..
|
|
|
|
Post by babaoriley on Jun 29, 2020 12:49:23 GMT -5
As a private Investor, my job is to invest my money and make money! Not to invest my money and lose my money! I work hard for my money and when I invest I expect to see a return. As a public company, Mannkind Corporation's job is to make their investors money. In this case, their job is to make me money. I invested in them, I will hold them accountable, and I will expect to see a return. So far, I'm underwater and holding my breath. I failed as an investor and Mannkind management has failed me. Like I said I haven't quit, I'm holding my breath, but Mike, I'll need oxygen soon, please don't quit me! They haven't failed me as a customer and for this reason alone a portion of my money continues to be invested in them, having said that, it doesn't mean you are precluded from other investments. It's the choices we make where accountability lies, I take full responsibility for my own actions and decisions after doing my own due diligence. You can read and choose to listen to others opinions etc., but at the end of the day it's the choices we make whether to remain invested. This has and remains a speculative investment, key word is speculative...high risk, high reward. If I wanted a conservative investment with expected returns I would be in a large cap with a stable history of dividends. The history of this investment is very indicative of what comes with a speculative investment. Thus why I have said in the past, it's a Rip Van Winkle stock, hopefully one day I wake up to a nice surprise but I don't watch it like a pot about to boil. Even MTOI says one day hopefully his daughter will wake up with a lot of money Joey, my thinking was the same as yours up to about a year or so ago. What has changed for me is that I no longer see a large upside. I see a modest upside, maybe $4, a nice double, but it throws the risk/reward proportion into a place where I do not care to invest more, nor hold as much as I used to. I guess the shares/options that I have sold over the last year have been gobbled up by Mytakeonit. |
|
|
|
Post by ryster505 on Jun 29, 2020 12:57:05 GMT -5
They haven't failed me as a customer and for this reason alone a portion of my money continues to be invested in them, having said that, it doesn't mean you are precluded from other investments. It's the choices we make where accountability lies, I take full responsibility for my own actions and decisions after doing my own due diligence. You can read and choose to listen to others opinions etc., but at the end of the day it's the choices we make whether to remain invested. This has and remains a speculative investment, key word is speculative...high risk, high reward. If I wanted a conservative investment with expected returns I would be in a large cap with a stable history of dividends. The history of this investment is very indicative of what comes with a speculative investment. Thus why I have said in the past, it's a Rip Van Winkle stock, hopefully one day I wake up to a nice surprise but I don't watch it like a pot about to boil. Even MTOI says one day hopefully his daughter will wake up with a lot of money Joey, my thinking was the same as yours up to about a year or so ago. What has changed for me is that I no longer see a large upside. I see a modest upside, maybe $4, a nice double, but it throws the risk/reward proportion into a place where I do not care to invest more, nor hold as much as I used to. I guess the shares/options that I have sold over the last year have been gobbled up by Mytakeonit. A nice double? So a max $800mm Market Cap? Lol, to each their own....Sorry you feel so drab out Mannkind at this stage of the game. |
|
|
|
Post by radgray68 on Jun 29, 2020 14:05:11 GMT -5
If $4 is the highest this stock gets, after 5 years, that's still like 16% CAGR over the 5 years. Not bad at all. And that's if you bought some at $1.85 like I did today. Add in some extra income on the side selling puts and calls and this stock has still got appeal.......for me.
BTW one could easily support a DCF model that takes us to $8 or more in 5 years, I believe. Think expanded mkt. for Tre-T, steady Afrezza sales increase to include pediatrics. Not to mention my favorite variable, the new orphan lung focus. A partnered cancer drug HAS to be in the discussion over the next 5 years as well. That's next level cash $ 😀 IMHO
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Jun 29, 2020 14:09:54 GMT -5
They haven't failed me as a customer and for this reason alone a portion of my money continues to be invested in them, having said that, it doesn't mean you are precluded from other investments. It's the choices we make where accountability lies, I take full responsibility for my own actions and decisions after doing my own due diligence. You can read and choose to listen to others opinions etc., but at the end of the day it's the choices we make whether to remain invested. This has and remains a speculative investment, key word is speculative...high risk, high reward. If I wanted a conservative investment with expected returns I would be in a large cap with a stable history of dividends. The history of this investment is very indicative of what comes with a speculative investment. Thus why I have said in the past, it's a Rip Van Winkle stock, hopefully one day I wake up to a nice surprise but I don't watch it like a pot about to boil. Even MTOI says one day hopefully his daughter will wake up with a lot of money Joey, my thinking was the same as yours up to about a year or so ago. What has changed for me is that I no longer see a large upside. I see a modest upside, maybe $4, a nice double, but it throws the risk/reward proportion into a place where I do not care to invest more, nor hold as much as I used to. I guess the shares/options that I have sold over the last year have been gobbled up by Mytakeonit. Baba, are you soured by the dilution, or the inept CEO? Or, both? Or, something else? I do not see a change in upside potential. I just don't know that this CEO can ever even get us there ... let alone do it last year. |
|
|
|
Post by cretin11 on Jun 29, 2020 14:54:31 GMT -5
Anybody who has been around as long as baba remembers the projected market share for Afrezza. No need to state the specific numbers, but suffice it to say the reality has proven to be a tiny sliver of what our worst nightmare projections were.
And back then we also were told about “veins of gold” so we were adding that into our upside potential for MNKD.
Post approval shares were in the $55 to $60 range, and we wanted a 10x return from there! That’s right, folks were talking about share price of $100, pre reverse split. And people weren’t mocking them back then (no offense MTOI). That math means we’d need to get to $500 to $600 per share to reach what we thought our upside was then. Even MTOI’s wildest predictions haven’t reached that number (MTOI whaddya say, will you raise your estimate from $100 to $500 now? You can do it!).
To sum it up, it’s hard to argue with baba’s conclusion that MNKD’s upside is not what it was. Is the upside $4? Even I hope it’s higher than that, but we’d probably sell the company today to get that price.
|
|
|
|
Post by prcgorman2 on Jun 29, 2020 15:39:07 GMT -5
$4 in an exchange with average P/E of 27:1 and a sector that’s usually higher? And that’s the best you can hope for? Buh bye.
|
|
|
|
Post by parrerob on Jun 29, 2020 15:49:29 GMT -5
Hi Cretin.... sorry but better to speak about market cap instead of pps.... in 2014, August, market cap was 4 billion (10$ / share)... and someone spoke about a market of 1+ billion sales....
Today a 4 billion market cap equal approx to 16$ / share.... so totally different situation.
Me as risk investor (I call it my venture capital) I try to put money in innovations specially in area where Human beeing could improve the quality of time we spend here in this world...
My father suffered diabetic quite all of his Life. He was good managing daily insuline injections but If he could try Afrezza I Am sure He had liked so much specially life quality improvements...(He suffered a lot low glucose moments, always with sugar and charmes in the pocket).
He died because of Parkinson (very bad and terrible illness).
This is more or less the Reason why, me, as venture capital, I am investing in MNKD and ACAD (both since 2014).
Speaking about ACAD the market cap is about 8 million... drug was approved after Afrezza and company is still loosing more then 200 million $ / year (but with sales now at 300 millions).. different market, different story... but 8 billion (1 drug, 1 platform as MNKD) cap with 200+ million cash burnt in 2019... so why not dreaming MNKD too towards 8 million market cap? Once Afrezza will be at 100 million sales and increasing, second drug in the market with increasing revenues, third drug in the pipeline.... this could happen in 18 months... 30$ a share? Why not....
Not to forget that other then MNKD and ACAD I Am also investing in 'my Low risk fund' composed by V, AMZN, BABA, STM....
And trying to keep some cash as well:
40% cash
30% what I call very long term low risk
30% what I call very long term venture capital (dedicated to my father, benefits If any, to my son)
|
|
|
|
Post by cretin11 on Jun 29, 2020 16:13:07 GMT -5
Hi Cretin.... sorry but better to speak about market cap instead of pps.... in 2014, August, market cap was 4 billion (10$ / share)... and someone spoke about a market of 1+ billion sales.... Today a 4 billion market cap equal approx to 16$ / share.... so totally different situation. Me as risk investor (I call it my venture capital) I try to put money in innovations specially in area where Human beeing could improve the quality of time we spend here in this world... My father suffered diabetic quite all of his Life. He was good managing daily insuline injections but If he could try Afrezza I Am sure He had liked so much specially life quality improvements...(He suffered a lot low glucose moments, always with sugar and charmes in the pocket). He died because of Parkinson (very bad and terrible illness). This is more or less the Reason why, me, as venture capital, I am investing in MNKD and ACAD (both since 2014). Speaking about ACAD the market cap is about 8 million... drug was approved after Afrezza and company is still loosing more then 200 million $ / year (but with sales now at 300 millions).. different market, different story... but 8 billion (1 drug, 1 platform as MNKD) cap with 200+ million cash burnt in 2019... so why not dreaming MNKD too towards 8 million market cap? Once Afrezza will be at 100 million sales and increasing, second drug in the market with increasing revenues, third drug in the pipeline.... this could happen in 18 months... 30$ a share? Why not.... Not to forget that other then MNKD and ACAD I Am also investing in 'my Low risk fund' composed by V, AMZN, BABA, STM.... And trying to keep some cash as well: 40% cash 30% what I call very long term low risk 30% what I call very long term venture capital (dedicated to my father, benefits If any, to my son) parrerob I respect your decision to invest in companies that can do good for people. I love doing that too, however my main objective in choosing stocks is to choose ones that will provide a strong return on investment. Your prediction of $30 per share within 18 months is wildly optimistic in my opinion. But that’s what makes this fun, we all get to have our predictions and none of us really know what will happen. My prediction is somewhere between yours and baba’s (definitely closer to baba’s), but my HOPE is that you are correct. And really my hope/dream/delusion is that MTOI is right! LOL |
|
|
|
Post by morfu on Jun 29, 2020 18:06:44 GMT -5
Hi Cretin.... sorry but better to speak about market cap instead of pps.... in 2014, August, market cap was 4 billion (10$ / share)... and someone spoke about a market of 1+ billion sales.... Today a 4 billion market cap equal approx to 16$ / share.... so totally different situation. Me as risk investor (I call it my venture capital) I try to put money in innovations specially in area where Human beeing could improve the quality of time we spend here in this world... My father suffered diabetic quite all of his Life. He was good managing daily insuline injections but If he could try Afrezza I Am sure He had liked so much specially life quality improvements...(He suffered a lot low glucose moments, always with sugar and charmes in the pocket). He died because of Parkinson (very bad and terrible illness). This is more or less the Reason why, me, as venture capital, I am investing in MNKD and ACAD (both since 2014). Speaking about ACAD the market cap is about 8 million... drug was approved after Afrezza and company is still loosing more then 200 million $ / year (but with sales now at 300 millions).. different market, different story... but 8 billion (1 drug, 1 platform as MNKD) cap with 200+ million cash burnt in 2019... so why not dreaming MNKD too towards 8 million market cap? Once Afrezza will be at 100 million sales and increasing, second drug in the market with increasing revenues, third drug in the pipeline.... this could happen in 18 months... 30$ a share? Why not.... Not to forget that other then MNKD and ACAD I Am also investing in 'my Low risk fund' composed by V, AMZN, BABA, STM.... And trying to keep some cash as well: 40% cash 30% what I call very long term low risk 30% what I call very long term venture capital (dedicated to my father, benefits If any, to my son) >> market cap was 4 billion (10$ / share)... and someone spoke about a market of 1+ billion sales You mean Afrezza sales for adults in USA by that, right? (the current numbers are about a factor of 15 away from that goal) But of course Techoshpere has a lot of other applications, a few are already actively pursued, so this number seems low as a long term goal. Assuming a 50% revenue, this translates to about 2$ per share (assuming the management can restrain itself to about current share numbers) and a factor 8 to your expected 16$ share price.
The EPS to share ratios for promising companies in the Bio sector is typically a lot higher, factors above 200 are common, as long as the company has more potential and Techosphere very much has! So, your prognosis of a share price of 16$ when the revenue is about 2$ per share seems at least an order of magnitude too pessimistic, when you compare it to other companies.
|
|
|
|
Post by bthomas55ep on Jun 29, 2020 19:42:36 GMT -5
When you see Novavax (who of course has a "potential" COVID Vaccine -- big deal, i know), goes from $3.84 to $88 a share just this year, you do begin to believe a lot of things are possible if the company can just hit on something that will have high growth. finance.yahoo.com/quote/NVAX?p=NVAXI am holding more shares than I've ever had, but I'm just not sure I could hold it through $100 unless it happened fast like NVAX. Good luck to all. Much more optimistic lately. Been invested a long time. |
|
